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Abstract 16 
  17 
The in vitro fermentation selectivity of purified galactooligosaccharides (GOS) after 18 
their conjugation with bovine -lactoglobulin ( -LG) via the Maillard reaction and a 19 
subsequent simulated gastrointestinal digestion was evaluated. Changes in human faecal 20 
bacterial populations, lactic acid and short-chain fatty acids after 10 and 24h of 21 
fermentation of the digested -LG:GOS conjugates revealed that this mixture of glycated 22 
peptides had a similar bifidogenic activity to the unconjugated GOS. These findings could 23 
open up new applications of Maillard reaction products in the functional foods field. 24 
25 
 3 
1. Introduction. 26 
 27 
Protein glycation is frequently used to improve protein functionality and, 28 
consequently, to obtain new functional food ingredients with improved biological and 29 
technological properties (Oliver, Melton, & Stanley, 2006). Previously, the glycation of 30 
bovine β-lactoglobulin (β-LG) with galactooligosaccharides (GOS) with polymerization 31 
degrees from 2 to 7 was evaluated (Sanz, Corzo-Martinez, Rastall, Olano, & Moreno, 32 
2007). In vitro simulated gastrointestinal digestion revealed the complete hydrolysis of 33 
unglycated and glycated -LG and the formation of stable glycated peptides which were 34 
characterised by LCESI-MS/MS (Moreno, Quintanilla-Lopez, Lebron-Aguilar, Olano, & 35 
Sanz, 2008).  36 
Some in vitro studies and in vivo experiments in rats have shown that non-digested 37 
Amadori compounds, the first stable intermediates in the Maillard reaction, could reach the 38 
colon where they are fermented by microorganisms (Erbersdobler, & Faist, 2001; Faist, & 39 
Erbersdobler, 2001; Finot, 2005). Therefore, the conjugation between prebiotic 40 
carbohydrates and food proteins could potentially allow carbohydrates to reach the distal 41 
parts of the colon, where many chronic gut disorders originate (Gibson, Probert, Loo, 42 
Rastall, & Roberfroid, 2004). However, it is vital to confirm that prebiotics maintain their 43 
fermentation selectivity when they are linked to peptides. There is currently very little 44 
information on fermentation selectivity of Maillard reaction products. A non-specific 45 
increase in the anaerobic bacteria was reported after the fermentation of  melanoidins, final 46 
products of Maillard reaction, produced from an aqueous glucose–lysine model system 47 
(Ames, Wynne, Hofmann, Plos, & Gibson, 1999). Also, bread crust melanoidins stimulated 48 
 4 
growth of bifidobacteria (Borrelli, & Fogliano, 2005). In contrast, other studies showed that 49 
bovine serum albumin (BSA) glycated with glucose promoted the growth of detrimental 50 
species of bacteria (sulphate-reducing bacteria and clostridia) instead of that of  51 
bifidobacteria and lactobacilli compared to native BSA (Tuohy et al., 2006). Moreover, 52 
pure culture studies revealed that Maillard reaction products derived from roasted cocoa 53 
bean reduced the growth of E. coli spp., Enterobacter cloaceae and bifidobacteria (Summa 54 
et al., 2008). 55 
Nevertheless, none of the aforementioned studies evaluated the effect of a protein 56 
glycated with prebiotic carbohydrates on the growth of human gut bacteria after an in vitro 57 
gastrointestinal (GI) digestion. Huebner, Wehling, Parkhurst, & Hutkins, (2008) studied the 58 
effect of Maillard reaction conditions on the prebiotic activity of different commercial 59 
fructooligosaccharides (FOS) conjugated with glycine using pure culture assays. However, 60 
these prebiotics were not previously fractionated and the formation of the MRPs could be 61 
attributed to the presence of minor reducing sugars such as glucose and fructose.  62 
Therefore, the objective of this study was to evaluate the fermentation selectivity of 63 
simulated GI-digested β-LG glycated with purified GOS (β-LG:GOS) using small-scale 64 
pH-controlled fecal batch cultures and to compare with previously documented activity of 65 
GOS (Palframan, Gibson, & Rastall, 2003; Tzortzis, Goulas, Baillon, Gibson, & Rastall, 66 
2004; Vulevic, Rastall, & Gibson, 2004) in order to determine the effect of glycation. 67 
 68 
2. Materials and Methods. 69 
2.1. Glycation of β-lactoglobulin with GOS. 70 
 5 
The glycation was carried out following the method of Sanz et al. (2007) with some 71 
modifications. Aliquots of β-LG (mixture of A and B variants, Sigma-Aldrich, (St. Louis, 72 
MO, US)) and Vivinal-GOS
®
 (kindly provided by Friesland Foods Domo, Zwolle, The 73 
Netherlands), previously purified by SEC to remove mono- and disaccharides (Hernández, 74 
Ruiz-Matute, Olano, Moreno, & Sanz, 2009), were mixed (1:1, w:w) in 0.1 M sodium 75 
phosphate buffer (pH 7.0), freeze dried and kept under vacuum in a desiccator (40 ºC, aw: 76 
0.44, 16 days). Unglycated β-LG without GOS was dissolved in 0.1 M sodium phosphate 77 
buffer (pH 7.0), freeze dried and incubated under the same conditions to be used as control.  78 
2.2. Determination of conjugated GOS. 79 
After the storage of -LG and GOS, the unconjugated GOS fraction was removed 80 
by ultrafiltration using a diafiltration unit Model 8400 (Millipore Corp., Bedford, MA, 81 
USA) with a molecular weight cut-off of 10 kDa; the retentate was analyzed by ESI-MS to 82 
confirm the absence of unconjugated GOS. The permeate was analysed by gas 83 
chromatography-mass spectrometry (GC-MS) using a two-step derivatization (oximation 84 
and trimethylsilylation) as previously reported by Hernandez et al. (2009) to determine the 85 
percentage of unconjugated GOS (tri- and tetrasaccharide fractions). Thus, the quantity of 86 
conjugated GOS was calculated by using this equation: 87 
GOS conjugated = Total GOS - GOS unconjugated 88 
where total GOS is the amount of tri- and tetrasaccharide fractions, quantified by 89 
GC, used at the initial of the conjugation process.  90 
 91 
 6 
2.3 Gastrointestinal digestion and characterization of -LG:GOS conjugates. 92 
β-LG:GOS conjugates and the unglycated β-LG were digested following the 93 
simplified method proposed by Moreno, Mellon, Wickham, Bottrill, & Mills (2005) and 94 
characterized as indicated by Sanz et al. (2007) and Moreno et al. (2008). 95 
 96 
2.4 In vitro fermentations and analyses. 97 
 98 
Faecal samples were obtained from three healthy donors (aged 25-30 years old). 99 
Samples were diluted (1:10, w:v) with phosphate buffer (0.1 M, pH 7.4) and homogenised 100 
in a stomacher for 2 min at normal speed. Small scale pH controlled batch cultures (pH 101 
between 6.7 and 6.9) were used for the incubation of 50 mg of digested β-LG, β-LG:GOS 102 
and free GOS (positive control) with  0.05 mL of the faecal slurry at 37 ºC dissolved in 5 103 
mL of autoclaved nutrient basal medium. In addition, a control without substrate was 104 
carried out (negative control). Samples were taken after 0, 10 and 24 h of incubation. 105 
Fluorescent in situ hybridization (FISH) was carried out following the method proposed by 106 
Martin-Pelaez et al. (2008) using 16S rRNA-targeted oligonucleotide probes labelled with 107 
Cy3. Probes (Sigma) were as follows: Bif164 specific for Bifidobacterium (Langendijk et 108 
al., 1995), Bac303 specific to Bacteroides (Manz, Amann, Ludwig, Vancanneyt, & 109 
Schleifer, 1996), Chis150 for the Clostridium histolyticum group clusters I, II (Franks et al., 110 
1998), Erec482 for the Clostridium coccoides – Eubacterium rectal group (Franks et al., 111 
1998), Lab158 for Lactobacillus-Enterococcus group (Harmsen, Elfferich, Schut, & 112 
Welling, 1999) and Ato291 for the Atopobium cluster (Harmsen et al., 1999). For total 113 
counts the nucleic acid stain 4,6-diamino-2-phenylindole (DAPI) was used. Cells were 114 
 7 
manually counted using a Nikon Eclipse E400 fluorescent microscope (Nikon Instruments 115 
Europe, Kingston, UK). A minimum of 15 random fields were counted in each slide. Short-116 
chain fatty acids (SCFA) were analysed as indicated by  Sanz, Gibson, & Rastall. (2005) 117 
using an HPLC system (Hewlett-Packard HP1050 series, Agilent Technologies, Edinburgh, 118 
UK) equipped with a UV detector and an automatic injector. The column was an ion-119 
exclusion Aminex HPX-87H (7.8 x 300 mm, Bio-Rad, Hertfordshire, UK) maintained at 50 120 
°C. The eluent was 0.005 mmol L
-1
 sulfuric acid in HPLC grade water, and the flow was 121 
0.6 mL min
-1
. Detection was performed at 210 nm, and data were acquired using Chem 122 
Station for LC3D software (Agilent Technologies). 123 
 124 
2.5 Statistical analysis. 125 
 126 
  Each bacterial group and SCFA was compared by using one-way ANOVA test 127 
followed by a Scheffe test as a post hoc comparison of means (P<0.05) using Statistica for 128 
Windows version 6 (2002) by Statsoft Inc. (Tulsa, OK, USA).  129 
 130 
3. Results and Discussion 131 
 132 
3.1. Characterization of the -LG:GOS conjugates. 133 
 134 
Bovine β-LG was efficiently glycated with GOS after the optimization of incubation 135 
conditions in order to obtain the maximum formation of the corresponding Amadori 136 
compounds, as previously shown (Sanz, Cote, Gibson, & Rastall., 2006). Before simulated 137 
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GI digestion, free GOS were successfully removed from the -LG:GOS conjugates by 138 
diafiltration. GC-MS analyses of initial GOS concentration and unconjugated GOS after 139 
storage revealed that the ratio β-LG:GOS was approximately 2:1 (w:w). This information 140 
was necessary to utilize an equivalent proportion of free GOS in the positive controls used 141 
for fermentation in the batch culture systems with respect to the GOS linked to the peptidic 142 
chain by the glycation process.  143 
β-LG:GOS samples were submitted to GI digestion and were analysed by LC-MSn, 144 
identifying, as published before (Moreno et al., 2008), nineteen peptides glycated with GOS 145 
of different polymerization degree (up to 7 hexose units).  These samples were used for in 146 
vitro incubation with faecal inoculums.   147 
 148 
3.2. Changes in bacterial populations during in vitro batch culture fermentation. 149 
 150 
Table 1 shows changes in bacterial populations during the incubation of β-LG:GOS, 151 
GOS and digested β-LG with the faecal samples. The total bacterial population increased 152 
with all treatments, but this effect was only significant after 24 h. A significant increase in 153 
bifidobacteria population was observed after both 10 and 24 h for free GOS and for the 154 
digested -LG:GOS conjugates. However, no significant differences in the growth of these 155 
bacteria were observed between these samples. On the contrary, bifidobacteria did not show 156 
a significant growth during incubation with the unconjugated digested β-LG. Regarding 157 
Lactobacillus-Enterococcus group population, an increase during incubation with GOS, β-158 
LG:GOS and β-LG at 24h of fermentation was observed, although no significant changes at 159 
10h were detected. Counts of Bacteroides and Clostridium coccoides -Eubacterium rectal 160 
 9 
group were increased with all treatments, these changes being more notable for GOS and β-161 
LG:GOS at 24 h and for β-LG:GOS at 10 and 24 h, respectively. On the other hand, 162 
Clostridium histolyticum group clusters I, II, only showed significant differences at 24h of 163 
fermentation with GOS and β-LG:GOS as compared to the control, whereas Atopobium 164 
population did not showed significant differences during the fermentation in all treatments.   165 
The bifidogenic in vitro response of the colonic microflora to GOS has been well 166 
documented (Palframan, et al., 2003; Tzortzis, et al., 2004; Vulevic, et al., 2004), but the 167 
selectivity of these carbohydrates conjugated with food proteins has not been reported. Our 168 
results indicate that the bifidogenic properties of GOS were retained after glycation. 169 
Furthermore, bacteroides, clostridia and atopobium populations had a similar behaviour 170 
after fermentation of digested -LG:GOS conjugates as compared to that of the well-known 171 
prebiotic GOS. Taken together, these results reinforce the fact that prebiotic properties of 172 
GOS, in terms of bacteria selectivity, are not modified following its glycation under 173 
controlled conditions. Similar results were found by Huebner et al. (2008), although these 174 
authors studied fructan-type oligosaccharides conjugated with glycine after heating at high; 175 
consequently, compounds different from those of Amadori should be formed in notable 176 
amounts. Moreover, the prebiotics tested by Huebner et al. (2008) contained remaining 177 
mono- and disaccharides, such as sucrose, glucose and fructose and the authors concluded 178 
that it was likely that these carbohydrates were responsible for the formation of MR 179 
products. 180 
 181 
3.3. SCFA and lactic acid production. 182 
 183 
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Table 2 shows the values obtained for lactic acid and SCFA production during the 184 
incubation with the different tested subtracts. Only acetic, lactic and propionic acids were 185 
detected in the samples. A significant increase of lactic and acetic acids was observed in the 186 
presence of GOS at 10 and 24 h, whereas only lactic acid significantly increased for β-LG 187 
and β-LG:GOS. Acetic and lactic acids are fermentation end-products of the bifidobacteria 188 
pathways (Sanz et al., 2005; Sanz et al., 2006), however, it is difficult to relate the 189 
production of these acids with one bacterial genus when mixed cultures are studied. On the 190 
other hand, no significant differences were observed for propionic acid.  191 
 192 
4. Conclusions 193 
 194 
The glycation of -LG with GOS under controlled conditions did not affect the in 195 
vitro fermentation selectivity of these carbohydrates. Previous research has demonstrated 196 
the undigestibility of the Amadori compound, which may conceivably reach the distal 197 
region of the colon (Erbersdobler, & Faist, 2001; Faist, & Erbersdobler, 2001; Finot, 2005). 198 
In consequence, although in vivo studies should be conducted, glycation involving prebiotic 199 
carbohydrates and peptides might be an alternative to obtain a new generation of prebiotics 200 
with enhanced colonic persistence. Lastly, it would be worth exploring the potential 201 
combination of the prebiotic properties with other bioactivities provided by the peptidic 202 
sequence.  203 
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Table 1. Bacterial populations (log 10 cells mL
-1
 batch culture) in pH controlled cultures at 0, 10 and 24 hours of fermentation using 297 
GOS, β-LG:GOS and β-LG. 298 
*Different letters indicate significant differences (P ≤ 0.05) for each bacterial group. 299 
** Samples had been submitted to in vitro gastrointestinal digestion 300 
§ 
Standard deviation (n=3). 301 
Treatment Time 
(h) 
Total cells Bifidobacteria Bacteroides 
Lactobacillus-
Enterococcus 
group 
Clostridium 
histolyticum 
group clusters 
I, II, 
Atopobium 
group 
Clostridium 
coccoides -
Eubacterium 
rectal group 
Control 0 9.02  (0.02)
§
 
b* 
7.83 (0.01)
a 
8.00 (0.07)
d 
7.01 (0.11)
abc 
6.75 (0.05)
a 
7.97 (0.48)
a 
7.24 (0.06)
c 
No treatment 10 9.50 (0.02)
ab 
8.06 (0.01)
a 
8.09 (0.02)
cd 
6.91 (0.04)
a 
7.32 (0.01)
ab 
7.85 (0.0)1
a 
8.02 (0.20)
a 
24 9.78 (0.05)
ac 
7.92 (0.07)
a 
8.41 (0.07)
ab 
6.95 (0.16)
ab 
6.97 (0.03)
a 
7.32 (0.13)
a 
7.77 (0.22)
ab 
GOS 10 9.42 ( 0.02)
ab 
9.29 (0.07)
b 
8.41 (0.08)
ab 
7.12 (0.20)
abc 
7.30 (0.22)
ab 
7.45 (0.01)
a 
7.51 (0.08)
bc 
24 9.83 (0.01)
ac 
9.07 (0.05)
b 
8.76 (0.05)
e 
7.50 (0.04)
d 
7.69 (0.06)
b 
7.29 (0.14)
a 
7.92 (0.04)
ab 
β-LG:GOS** 10 9.45 (0.10)ab 9.18 (0.04)b 8.42 (0.08)ab 7.12 (0.11)abc 7.12 (0.22)ab 7.79 (0.08)a 8.17 (0.11)a 
24 10.03 (0.11)
c 
9.19 (0.04)
b 
8.59 (0.07)
be 
7.38 (0.04)
bcd 
7.68 (0.06)
b 
7.62 (0.08)
a 
8.11 (0.06)
a 
β-LG** 10 9.43 (0.04)ab 8.23 (0.10)a 8.32 (0.08)acd 6.87 (0.10)a 7.06 (0.14)ab 7.54 (0.09)a 7.51 (0.14)bc 
24 9.91 (0.11)
ac 
8.32 (0.11)
a 
8.33 (0.03)
ac 
7.42 (0.10)
cd 
7.29 (0.33)
ab 
7.43 (0.26)
a 
7.94 (0.11)
ab 
 16 
 302 
Table 2. SCFA and lactic acid concentration (mM) in pH controlled cultures at 0, 10 and 24 hours of fermentation using GOS, β-303 
LG:GOS and β-LG. 304 
 305 
 306 
 307 
 308 
 309 
 310 
 
311 
 
312 
 
313 
 
314 
*Different letters indicate significant differences (P ≤ 0.05) for each acid. 315 
§ 
Standard deviation. 316 
 317 
 318 
  Time Lactic acid Acetic acid Propionic acid 
Control 0 0.00 (0.00)
§a* 
1.01 (0.24)
b 
0.76 (0.20)
 ab 
No treatment 
10 0.00 (0.00)
a 
4.87 (0.61)
a 
0.78 (0.68)
 ab 
24 0.00 (0.00)
a 
5.23 (0.00)
b 
0.00 (0.00)
a 
GOS 
10 3.71 (0.29)
e 
27.94 (9.53)
c 
1.28 (0.53)
 ab 
24 3.44 (0.00)
f 
30.99 (7.80)
c 
3.48 (1.67)
b 
β-LG 
10 2.16 (0.32)
b 
5.80 (0.69)
a 
1.19 (0.25)
ab 
24 1.53 (0.29)
c 
6.39 (1.78)
ab 
2.25 (1.54)
ab 
β-LG:GOS 
10 2.39 (0.50)
b 
9.07 (3.40)
a 
1.06 (0.11)
ab 
24 1.87 (0.04)
d 
6.52 (1.92)
ab 
2.02 (0.86)
ab 
